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The relative attenuation of self-stimulation, eating and drinking produced by dopamine-receptor
blockade

!
E. T. Rolls, B. J. Rolls, P. H. Kelly, S. G. Shaw, R. J. Wood, and R. Dale
!
University of Oxford, Department of Experimental Psychology, Oxford, England
!
!
Abstract
!

Spiroperidol, which blocks dopamine (DA) receptors, attenuated self-stimulation of the nucleus
accumbens, septal area, hippocampus, anterior hypothalamus and ventral tegmental area.
Dopamine is thus involved in self-stimulation of many sites (in addition to the lateral
hypothalamus). The attenuation was not a simple motor impairment of the speed of bar-pressing
in that the nucleus accumbens and septal self-stimulation rates were lower than those in treated
animals self-stimulating at other sites (Experiment 1). Feeding was partly attenuated, and
drinking was much less attenuated by the spiroperidol. Since the rats bar-pressed for brainstimulation reward, chewed pellets to eat, and licked a tube to drink, dopamine-receptor blockade
may attenuate complex motor responses most. Alternatively, the blockade could affect brainstimulation reward more than the controls of eating, and these latter more than the controls of
drinking (Experiment 2). In Experiment 3, feeding and drinking were equally and severely
attenuated when rats had to bar-press to obtain food or water. The attenuation was to a level
similar to that found for self-stimulation. These experiments suggest that dopamine receptor
blockade impairs eating, drinking and self-stimulation by interfering with complex motor
responses.

!

!
Introduction
!

There is evidence that dopamine receptors are involved in brain-stimulation reward. Selfstimulation of the hypothalamus through implanted electrodes is attenuated by the administration
of agents which block dopamine (DA) receptors, for example, haloperidol (Stein, 1967), and the
more specific pimozide (Wauquier and Niemegeers, (1972) and spiroperidol (Kelly, Rolls, and
Shaw, 1973). Chlorpromazine, which blocks noradrenaline (NA) and DA receptors about equally
(Andén, Butcher, Corrodi, Fuxe, and Ungerstedt, 1970) also reduces hypothalamic selfstimulation rate (Stein and Ray, (1960); Stark, Turk, Redman, and Henderson, 1969). Selfstimulation can be obtained in the A9 and A10 areas of Fuxe and Dahlström (1965), that is, in the
region of the substantia nigra and intrapeduncular nucleus (Crow, 1972; Anzelark, Arbuthnott,
Christie, and Crow, 1973), where dopamine-containing cell bodies are found.

!

There is also evidence that the attenuation of self-stimulation produced by dopamine-receptor
blockade is relatively specific, at least with respect to arousal. Thus spiroperidol (which blocks
DA receptors) produces complete attenuation of lateral hypothalamic self-stimulation in doses
!1

which have only small effects on arousal measured by locomotor activity and rearing. This is in
contrast to the effects of NA-receptor blockade or the depletion of brain NA by disulfiram, which
produce a much more marked attenuation of arousal than of self-stimulation (Kelly et al., 1973;
Rolls, Kelly, and Shaw, 1974). This evidence indicates that dopamine receptors are involved in
self-stimulation of at least some sites, in particular in self-stimulation of the lateral hypothalamus
and of the region of DA-containing neurones near the substantia nigra (see also Rolls, 1974).

!

The purpose of Experiment 1 is to determine whether dopamine receptors are involved in selfstimulation of sites other than the lateral hypothalamus and region of the substantia nigra. In
Experiment 1 dose-response curves of the effects of spiroperidol which produces specific
dopamine-receptor blockade (Andén et al., 1970), on self-stimulation of the nucleus accumbens,
septal region, anterior hypothalamus, hippocampus and ventral midbrain tegmentum were
performed. These experiments also give some evidence on whether DA-receptor blockade
attenuates self-stimulation by producing an impairment in the ability of the animals to par-press,
that is, in motor ability.

!

There is also some evidence that dopamine-containing pathways are involved in feeding and
drinking. Ungerstedt (1971b) reported that if the nigro-striatal DA system (see Ungerstedt,
1971a) was selectively destroyed by local injections of 6-hydroxydopamine (6-OHDA) rats
became aphasic and adipsic (and also hypokinetic but not cataleptic). Oltmans and Harvey
(1972) showed that lesions of the nigrostriatal pathway produced aphasia and adipsia which were
correlated with the depletion of DA. In a further demonstration that DA pathways are involved in
eating, Ungerstedt (1971b) showed that the i.p. injection of pimozide, which blocks DA
receptors, attenuates eating. A critical question raised by this work is whether dopamine is
equally involved in eating, drinking, and self-stimulation. To examine this, dose-response curves
of the effect of spiroperidol (which blocks DA receptors) on food and water intake were made in
Experiments 2 and 3. These can be compared with the dose-response curves of the effect of
spiroperidol on self-stimulation obtained in Experiment 1.

!

Method

Experiment 1

!

!

Seven male Sprague-Dawley rats weighing 260-350 g at the start of the experiment were
implanted with arrays of up to 5 electrodes for self-stimulation. The electrodes were aimed at the
ventral tegmental area (VT), the hippocampus (HIPP), the anterior hypothalamus (AH), the
septal area (SEPT), and the nucleus accumbens using the coordinates shown in Fig. 1. At the
extermination of the experiments histological analysis (50 µ thionin-stained sections) showed
that the electrodes had been well placed for the different sites (Fig. 1). The electrodes were made
of size 00 stainless steel insect pins insulated to within 0.2mm of the tip, and were implanted
under Equi-thesin (Jensen-Salsbury) (3.0 ml/kg) anesthesia. The animals were tested for selfstimulation in box 26 cm × 16 cm × 38 cm. Depression of a bar at one end of the box switched

!
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Fig. 1. Examples of the stimulation sites are shown by the black dots. The level-head implementation co-ordinates
are: nucleus accumbens: 1.6 mm anterior to bregma, 0.8 mm lateral to the midline and 5.0 mm beneath the dura
(+1.6, 0.8, 5.0 mm); septum: 0.0, 0.5, 4.4 mm; anterior hypothalamus: -1.2, 1.4, 7.3 mm; ventral tegmental area:
-6.0, 0.8, 7.8 mm. The hippocampal electrodes were implanted at -4.5, 3.0, 3.0 mm (not illustrated). The brain
outlines are from König and Klippel (1963).

!!

on capacitively coupled 0.1 msec constant current stimulus pulses recurring at a frequency of
100 Hz for 0.3 sec. Current return was via screws implanted in the skull.

!

The animals were tested every second day, once in the morning after a placebo injection and
once in the afternoon after a drug or a placebo injection. The morning tests were used only to
check that the baseline rate of self-stimulation was constant over days for the different selfstimulation sites. The afternoon tests were used to construct a drug-response curve of the effect
of spiroperidol on self-stimulation. The order of drug and placebo injections was completely
counterbalanced for subgroups of the rats, and was partially balanced overall. Each testing
session was as follows. First, there was a 3-min period of anterior hypothalamic self-stimulation.
Then self-stimulation rate was measured at each site for five minutes, with one-minute changeover periods between each site to allow the self-stimulation rate to stabilize at each site. The
number of self-stimulations at each site were measured over the five-minute periods. The sites
were always tested in the same order. The current at each site was chosen so that regular self!3

Fig. 2. Dose-response curves of the effect of spiroperidol on self-stimulation rate, expressed as a percentage of the
placebo rate. The points represent means ± S. E. The number of rats is indicated beside each point.

!!

stimulation without pauses occurred, and so that any change in current altered the selfstimulation rate. Thus the rate of self-stimulation at each site was a measure of the potency of the
stimulation. The currents for the different sites were approximately 1 1/2 times threshold. The
currents were held constant for each site for the duration of the experiment. With this procedure
self-stimulation at each site had its own characteristic rate (see Fig. 2).

!

The dopamine-receptor blocking agent used was spiroperidol (generously supplied by Janssen
Pharmaceutica, Beerse, Belgium) in doses of 0.02, 0.05 and 0.1 mg/kg. The drug was prepared
for intraperitoneal injection by dissolving 2.5 mg of spiroperidol and 7.5 mg of tartaric acid in 50
ml of water. For the dose of 0.1 mg/kg of spiroperidol, 2 ml/kg of this solution was injected. For
the smaller doses the solution was diluted so that the final amount of solution injected was still 2
ml/kg. The placebo injection was 2 ml/kg of 7.5 mg of tartaric acid dissolved in 50 ml of water.

!
Results
!

Dose-response curves for the effect of spiroperidol on self-stimulation at different sites are
shown in Fig. 2. For all the sites a dose-dependent decrease in self-stimulation rate was produced
by spiroperidol. This was true for individual rats as well as for the grouped data. (In Fig. 2 the
number of rats tested at the different doses varies first, because some of the rats pulled out their
!4

!
!!

Fig. 3. Dose-response curves of the effect of spiroperidol on absolute self-stimulation rate. Conventions as Fig. 2.

implants in the course of the experiment; second, because some rats did not self-stimulate on
every electrode, and third, because at the nucleus accumbens and AH sites at 0.1 mg/kg two rats
were tested twice as part of a balanced subgroup design). For comparison, dose response curves
for lateral hypothalamic self-stimulation are also shown in Fig. 2 (data from Rolls et al., 1974;
see Rolls, 1974). The baseline self-stimulation rates at the different sites are different. To
facilitate comparison between the different self-stimulation sites the results were also expressed
as percentages. The self-stimulation rate of each rat after a drug was expressed as a percentage of
its own self-stimulation rate after the placebo. The resulting dose-response curves are shown in
!5

Fig. 3. It is again clear that a dose-related decrease in self-stimulation rate at the different sites
was produced by spiroperidol.

!
Discussion
!

These results show that in addition to self-stimulation of the lateral hypothalamus, selfstimulation of the nucleus accumbens, septal area, hippocampus, anterior hypothalamus and
ventral tegmental area is attenuated in a dose-related manner by the administration of
spiroperidol. Spiroperidol produces significant dopamine-receptor blockade in doses between
0.01 and 0.1 mg/kg, and does not block NA receptors until higher doses (e.g. 5 mg/kg) are used
(Andén et al., 1970). Thus the attenuation of self-stimulation at these different sites is probably
related to the dopamine-receptor blockade produced by spiroperidol. (Other agents which block
dopamine receptors, e.g. pimozide, haloperidol and chlorpromazine, produce a similar
attenuation of hypothalamic self-stimulation—see Introduction). The dopamine receptors appear
to be involved in self-stimulation of a number of different brain regions.

!

The form of the spiroperidol dose-response curves also allows a conclusion about how the selfstimulation is attenuated. A given dose of spiroperidol (e.g. 0.05 mg/kg) appears to decrease selfstimulation rate relative to the baseline at all the sites tested (see Fig. 2).Yet at this drug dose
self-stimulation of the nucleus accumbens and septal area occurred slowly (at approximately 5
bar presses/min), and self-stimulation of the anterior hypothalamus and tegmental area was much
faster (at 20-50 bar presses/min). Thus the effect of the spiroperidol was not to attenuate selfstimulation of the nucleus accumbens and septal area by limiting how fast the animals could barpress. An impairment of the ability of the animals to bar-press rapidly thus cannot explain the
effects of dopamine-receptor blockade on self stimulation.

!

Experiment 2

!

The purpose of the experiment was to obtain dose-response curves for the effect of spiroperidol
on eating and drinking.

!
Method
!

The subjects were 12 male hooded (Lister) rats. The rats were food or water deprived at 12 noon
on the day before a test, and injected with spiroperidol the following morning. Doses of 0.016,
0.1, 0.316 and 1.0 mg/kg of spiroperidol dissolved in 0.01 M tartaric acid were injected i.p. in a
volume of 1 ml/kg. For eight rats the order of the drug doses and of the placebo (1 ml/kg of 0.01
M tartaric acid) was counterbalanced, and each rat was tested every fourth day. These rats were
tested at every drug dose, and on both the feeding and the drinking tests. To investigate the
lowest dose condition (0.016 mg/kg) further, the remaining four rats were tested with this dose
and with the placebo. The feeding tests and the drinking tests started 2 h 5 min after the injection.
For as a test of eating a measured amount of food (laboratory chow in pellet form) was placed in
the home cage, and was reweighed, together with spillage, after 15 min, 30 min, 45 min, 1 h, 2 h,
!6

Fig. 4. Dose-response curves of the effect of spiroperidol on eating and drinking in the rat (Experiment 2). The
points represent the mean ± S.E. of the intake of each rat expressed as a percentage of the mean intake after the
placebo (see text). The open symbols show the response in Experiment 3 of rats which bar-pressed to obtain food
(circle) or water (square) in a Skinner box.

!!

3 h and 4 h. Intake was expressed as a percentage of the group mean under the placebo condition.
For a test of drinking a burette of water was placed on the cage and readings were taken every
minute for ten minutes, and then at the same times as for feeding.

!
Results
!

Dose-response curves of the effect of spiroperidol on eating or drinking after 1 h are shown in
Fig. 4. It is clear that spiroperidol produces a greater reduction in eating than in drinking. The
time courses of the eating and drinking were very similar. Eating and drinking gradually stopped
over the first 45 min, and were very low for the next 3 h.

!
Discussion
!

Spiroperidol reduces self-stimulation rate more than feeding, and feeding more than drinking.
This may be seen by comparing Fig. 4 with Fig. 3 (and also with Fig. 33 of Rolls, 1974). For
example, a dose of 0.1 mg/kg of spiroperidol reduced self-stimulation rate to between 5 and 20%
at different sites, eating to 28.0 ± 7.8, and drinking to 81.5 ± 8.9% (mean ± S.E.). One possible
conclusion is that dopamine receptors are closely involved in brain-stimulation reward, and less
so in the controls of eating and drinking in that order. Another possibility is that spiroperidol
impairs motor behavior, and therefore produces a large attenuation of the complex response of
bar-pressing, less attenuation of the motor behavior of picking up and chewing food, and least
attenuation of the motor response of licking water from a tube. To test which of these
possibilities is correct, in Experiment 3 rats pressed a bar to obtain food or water, so that a
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complex motor response was involved in both feeding and drinking. If the dopamine receptor
blockade produced by spiroperidol acts by impairing motor behavior, then the feeding and
drinking should be affected equally by the spiroperidol. On this hypothesis, the impairment
should be similar to that found with self-stimulation, which was tested with a similar response. If
in contrast the spiroperidol impairs the control system involved in drinking least specifically,
then drinking should be least severely attenuated in this experiment.

!

Experiment 3

!

The purpose of this experiment was to determine whether the differential effect of spiroperidol
on feeding and drinking was due to differences in the complexity of the motor response in the
two situations. In this experiment the response required to obtain food or water is the same, i.e.
the rats must press a lever in a Skinner box.

!
Method
!

The subjects were 12 male hooded (Lister) rats. The method was the same as in Experiment 2
except that the doses of spiroperidol used were 0.016 and 0.062 mg/kg. These doses and the
placebo were injected in counterbalanced order. Each rat was tested 6 times, in each drug
condition with both food and water deprivation. Before the experiment began the rats had been
trained to work for food and water in Skinner boxes. Rewards of 0.1 ml tap water or 45 mg
Noyes food pellets were delivered for each bar press. No rat could obtain rewards of both food
and water during a single test session. Two hours and 15 min after the injection the rats were
placed in the Skinner boxes for 4 h. During this time the responses were monitored by
electromagnetic counters.

!
Results
!

The effect of spiroperidol on eating and drinking after one hour in the Skinner box is shown in
Fig. 5. When the response required to obtain food or water is the same, no difference is found in
the effect of spiroperidol on feeding and drinking. When required to work for food or water the
rats are much more sensitive to spiroperidol than in the ad lib situation (see the response to 0.062
mg/kg shown in Fig. 4). Most of the bar-pressing ceased within 15 min of the injection.

!
Discussion
!

The finding that self-stimulation of the septal area, nucleus accumbens, anterior hypothalamus,
hippocampus and ventral tegmental area is attenuated by spiroperidol provides an indication that
dopamine is involved in self-stimulation of many different brain sites. It has previously been
shown that dopamine is involved in self-stimulation of the lateral hypothalamus and substantia
nigra, in that self-stimulation of the lateral hypothalamus is attenuated by the dopamine-receptor
blocking agents pimozide (Wauquier and Niemegeers, 1972) and spiroperidol (Kelly, Rolls, and
Shaw, 1973; Rolls, Kelly, and Shaw, 1974) and self-stimulation of the substantia nigra is equally
!8

Fig. 5. Dose-response curve of the effect of spiroperidol on bar-pressing for food or water in a Skinner box.
Conventions as Fig. 4.

!

facilitated by d- and l-amphetamine which have an equipotent effect on dopamine (Phillips and
Fibiger, 1973). In addition we have observed that self-stimulation with electrodes in the region of
the locus coeruleus is attenuated by pimozide and spiroperidol.

!

The role of motor disturbance in the attenuation of self-stimulation produced by dopaminereceptor blocking agents is at present unclear. It is clear that a simple motor incapacitation cannot
account for the attenuation of self-stimulation at some sites (e.g., the septal area and nucleus
accumbens), in that the absolute rate of self-stimulation after spiroperidol is higher at other sites
(e.g., the lateral hypothalamus and midbrain tegmentum). (At these latter sites spiroperidol does
attenuate self-stimulation, but the base-line self-stimulation rate is higher). Thus the selfstimulation is not limited by the rate at which the animals can press the bar. A similar conclusion
seems probable for the squirrel monkey, in that intercranial injections of 4-8 µg of spiroperidol
can abolish self-stimulation, yet the animal can perform the motor response of touching the bar
(personal observation with M. J. Burton and S. G. Shaw). In both the rat and the monkey the
degree of catalepsy associated with the abolition of self-stimulation is small (Kelly et al., 1974).
Thus catalepsy may not account for the effect of dopamine-receptor blockade on self-stimulation,
and reward may be directly affected. However, it remains to be clearly shown that some
disturbance of motor behavior does not account for the effect of spiroperidol on self-stimulation.

!

It was observed that, in Experiment 1, after treatment with intraperitoneal spiroperidol rats often
self-stimulated for 1-2 min when first tested for self-stimulation before a total abolition of selfstimulation became apparent. (This was despite the long injection-test interval). At this time the
rats usually faced the self-stimulation bar. The effect did not recur when subsequent sites were
tested on a particular day. A sudden cessation of relatively fast bar-pressing also occurred when
rats worked for food or water (Experiment 3).

!
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When a complex response, bar-pressing, was required to obtain either food or water, then the
feeding and drinking were equally and severely affected by spiroperidol (Experiment 3). The
impairment was comparable to that found for self-stimulation, in which bar-pressing was also the
response required (Rolls, 1974; Rolls et al., 1974). Thus it appears that the main effect of
dopamine-receptor blockade on feeding, drinking and self-stimulation is accounted for by an
effect on motor behavior. In Experiment 2, it appears that drinking was relatively little affected
by spiroperidol due to the relatively simple nature of the licking required to obtain water. There
is no evidence that dopamine-receptor blockade interferes specifically with the controls of
drinking. Such evidence would require careful elimination of effects on motor behavior produced
by the dopamine-receptor blockade.

!

The impairment in bar-pressing for food or water (Experiment 3) was at least as great as the
impairment in bar-pressing for brain-stimulation reward (Experiment 1, Rolls, 1974; and Rolls et
al., 1974). (The impairment may appear to be greater, due perhaps to the shorter test period used
in the self-stimulation experiments.) This finding suggests that impairment of motor function
accounts for the effects of dopamine-receptor blockade on self-stimulation. The motor
impairment appears to be at a relatively central level, in that absolute bar-pressing rate was not
primarily affected by the treatment (see Experiment 1).

!

The conclusion that dopamine-receptor blockade attenuates drinking, eating and self-stimulation
by an impairment of central motor systems is consistent with other findings. Wauquier and
Niemegeers (1972) show that many types of avoidance behavior, as well as rewarded behavior,
are equally impaired by pimozide. This interpretation of the effect of dopamine-receptor
blockade on eating, drinking and self-stimulation in animals is consistent with the view that in
man disturbances of dopamine function in the extra-pyramidal motor system lead tot he lack of
voluntary behavior seen in Parkinsonism (Hornykiewicz, 1973; Sacks, 1973).

!
This work was supported by the Medical Research Council.
!

Note: In a replication of one of the findings of Experiments 2 and 3, it was found that
spiroperidol (0.316 mg/kg) produced a greater (N = 10, P < 0.005, one-tailed t-test) attenuation
of bar-pressing for water (7.0% of mean placebo) than of licking to obtain water (25.5% of mean
placebo) when the same rats used in both test situations in a fully counter-balanced design.

!
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